An observational study in Precocious Puberty, Central, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 4 Years to 11 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by University Hospital, Strasbourg, France · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This retrospective monocentric observational study aims to evaluate whether basal luteinizing hormone (LH) levels can reliably diagnose central precocious puberty and reduce the need for LHRH stimulation testing. Currently, all patients with suspected precocious puberty undergo LHRH testing regardless of basal LH levels.
The study will analyze pediatric patients evaluated between 2019 and 2024 to determine an optimal basal LH threshold with high specificity. Secondary analyses will assess diagnostic performance and explore clinical and biological factors influencing LH levels. The results may help reduce unnecessary testing and improve diagnostic strategies.
75 studies on the registry are indexed under Puberty, Precocious; 18 are open to participants now.
This study's planned enrollment of 100 is below the median of 300 across 26 observational studies indexed under Puberty, Precocious.
Browse Puberty, Precocious studies →University Hospital, Strasbourg, France is the lead sponsor of 1,000 studies on the registry; 359 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Children evaluated for suspected central precocious puberty in a pediatric day hospital setting, who underwent LHRH stimulation testing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Basal LH threshold for diagnosis of central precocious puberty
Determination of the basal LH level associated with a positive diagnosis of central precocious puberty (LH peak \>5 IU/L) and estimation of the number of LHRH stimulation tests that could have been avoided using this threshold.
Time frame: At time of diagnostic evaluation (retrospective data from 2019-2024)
Started Mar 2026 (actual). Primary completion is estimated for Nov 2026, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →